Pabella, Reyjane .
HRN: 27-76-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
CEFUROXIME 1.5GM (VIAL)
09/08/2025
09/09/2025
IVT
1.5gms
OD
S/P LSCS
Checking Initial Appropriateness
09/10/2025
CEFUROXIME 500MG (TAB)
09/10/2025
09/17/2025
PO
500mg
BID
S/P LSCS
Checking Initial Appropriateness